Literature DB >> 31256111

NAFLD evaluation: Which is more appropriate, multislice computed tomography or ultrasound real-time shear wave elastography?

Pinggui Lei1, Jun Jiao1, Hong Li2, Pingxian Wang3, Qinghong Duan1, Jing Liu1, Shi Zhou1, Qian Wei4, Xiaolin Wang1.   

Abstract

OBJECTIVE: This study aims to assess the value of ultrasound real-time shear wave elastography (US-SWE) for evaluation of nonalcoholic fatty liver disease (NAFLD) in a rabbit model compared with multislice computed tomography (MSCT).
MATERIAL AND METHODS: Twenty-six rabbits were fed with high-fat, high-cholesterol diet and six rabbits were fed with a standard diet. All rabbits were performed with MSCT and US-SWE at various time points to measure changes in liver parenchyma. The diagnostic efficiency of US-SWE was analyzed using receiver operating characteristics (ROC) curves compared with MSCT based on the liver pathology.
RESULTS: The statistically significant differences in the areas under the ROC curves between using MSCT and US-SWE modalities were detected to discriminate between normal vs. NAFLD or higher severity pathology. Similarly, for normal or NAFLD vs. borderline or NASH livers, statistically significant differences between using US-SWE and MSCT modalities were also detected for nonalcoholic steatohepatitis (NASH) vs. lower severity pathology.
CONCLUSIONS: MSCT, but not US-SWE, had a better ability to differentiate normal or NAFLD livers from higher severity NAFLD livers. However, the diagnostic efficiency of US-SWE was superior to that of MSCT for differentiating NASH from normal or lower severity NAFLD.

Entities:  

Keywords:  Shear wave elastography; diagnostic efficiency; multislice computed tomography; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Year:  2019        PMID: 31256111     DOI: 10.3233/XST-190502

Source DB:  PubMed          Journal:  J Xray Sci Technol        ISSN: 0895-3996            Impact factor:   1.535


  1 in total

1.  Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum.

Authors:  Qianjiao Liu; Hongfang Nie; Hengtian Xu; Pingxian Wang; Pinggui Lei
Journal:  Korean J Radiol       Date:  2020-08-04       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.